MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that John Kelley, Chief Executive Officer, will present a company overview at the Cowen and Company 36th Annual Health Care Conference in Boston on Monday, March 7, 2016 at 2:40 pm ET.
